UPRISENCT07238608
Impact of UFPs and MNPs on Fetal Health
At risk: Primary endpoint(s) modified.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Lead sponsor: Instituto de Investigacion Sanitaria La Fe to Alba Ruiz Gaitán Show 5 more changesShow less
- Primary endpoint(s) modified
- Eligibility criteria expanded, about 9 words
- Secondary endpoints expanded, about 6 words
- Collaborators: 2 to 3
- Study description expanded, about 2 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (1)
Arms and interventions
The study includes 1600 participants, providing a substantial sample for analysis. The focus is on newborns (age 0), making the study particularly relevant for understanding factors and outcomes related to this very early stage of life. The sex of the participants is expected to be randomly distributed. A control arm of full-term neonates (\>37 weeks) will be recruited for a 1:2 ratio in Greece and Spain. ENVIRONAGE, Belgium, employs a nested case-control design, making use of its prospective cohort framework that is already in place.
The study consists of 150 mothers, with 50 from each location. All participants are females aged over 18 years. The sex of the participants is expected to be randomly distributed.
Sites
1 site in 1 country
- Instituto de Investigación Sanitaria La FeValencia, Valencia, Spain